EMG-to-Text
Communication for speech-impaired patients
Pre-clinical/Proof-of-ConceptActive
Key Facts
Indication
Communication for speech-impaired patients
Phase
Pre-clinical/Proof-of-Concept
Status
Active
Company
About Synaptrix
Synaptrix Labs is an early-stage biotech company pioneering next-generation, non-invasive brain-computer interfaces (BCIs) powered by proprietary AI. Its initial focus is on assistive technology, with the Neuralis system aiming to restore mobility for paralyzed individuals through thought-controlled wheelchairs. The company is also developing a broader AI platform, NeuroDiffusion, for EEG/EMG signal processing and is exploring other applications like EMG-to-text communication. Currently in the clinical trial recruitment phase for Neuralis, Synaptrix has gained recognition through various startup competitions and accelerator programs like Nvidia Inception.
View full company profile